Journals / Çocuk Dergisi / 2009 / Cilt: 9 - Sayı: 4

Growth Hormone Therapy in Childhood: EvidenceBased Approach

Büyüme Hormonunun Tedavisinde Kanıta Dayalı Uygulamalar

Pages
158–166
Publication Date
2009-10-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, the effects of GH therapy on growth in different disorders in childhood and possible adverse effects will be reviewed with an evidence based approach.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Growth hormone GH is being used in GH deficiency GHD and also in recent years in other indications that go with short stature.
📊
Key Findings & Data:The aim of GH therapy is to increase the growth velocity at short term and improve final adult height at longterm.
💡
Conclusion & Impact:In this paper, the effects of GH therapy on growth in different disorders in childhood and possible adverse effects will be reviewed with an evidence based approach.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Büyüme hormonu · çocukluk çağı · büyüme

Abstract

Growth hormone GH is being used in GH deficiency GHD and also in recent years in other indications that go with short stature. The aim of GH therapy is to increase the growth velocity at short term and improve final adult height at longterm. Physiological doses of GH are used in GHD and higher doses in non- GHD conditions. There are several factors that have an effect on the growth response on GH treatment. The frequency of injections, replacement therapy of other hormones, if necessary, nutritional status, age at onset of therapy, GH dose and duration of therapy are some of these confounding factors. If GH therapy is given daily in adequate doses and started at younger ages the growth response will be beter. The prepubertal period is very important in obtaining a good growth response. In this paper, the effects of GH therapy on growth in different disorders in childhood and possible adverse effects will be reviewed with an evidence based approach.

Özet

Büyüme hormonu BH tedavisi giderek daha çok sayıda BH eksikliği BHE vakasında ve ayrıca, BHE dışında boy kısalığı ile giden çeşitli hastalıklarda uygulanmaya başlandı. BH tedavisinin amacı kısa dönemde büyüme hızını arttırmak ve uzun dönemde nihai boyun iyileştirilmesini sağlamaktır. BHE’de fizyolojik, BHE dışındaki diğer uygulamalarda ise daha yüksek BH dozları verilmektedir. BH tedavisine büyüme yanıtını etkileyen çeşitli faktörler vardır. Bu faktörler arasında BH verilme sıklığı, diğer hormonların varsa eksikliklerinin yerine konması, beslenme durumu, tedaviye başlama yaşı, BH dozu ve tedavi süresi sayılabilir. Tedavi hergün uygulanırsa, ne kadar erken yaşta başlanırsa ve uygun dozlarda verilirse büyüme yanıtı o kadar iyidir. Büyüme yanıtı özellikle prepubertal dönemde yüksektir. Bu derlemede BH tedavisinin çocukluk döneminde büyüme üzerine etkileri ve olası yan etkileri farklı hastalık gruplarında kanıta dayalı olarak sunulmaktadır

🔖

Cite This Article

DARENDELİLER, F. (2009). Growth Hormone Therapy in Childhood: EvidenceBased Approach. Çocuk Dergisi, Cilt: 9 - Sayı: 4, 158–166. https://ajindex.com/articles/247081

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Quigley CA. Growth hormone treatment of non-growth hor- mone deficient growth disorders. Endo Metab Clin North Am 2007; 36:131-86. Growth Hormone Therapy in Pediatrics. 20 years of KIGS. Ed. MB Ranke, DA Price, EO Reiter. Karger, Basel, 2007.
  2. Darendeliler F, Bundak R, Neyzi O. Hipofiz ön lobu. Pediatri kitabında. Ed. O Neyzi ve T Ertuğrul. Nobel Tıp Kitapevi 2002; 1215-21. ergenlik döneminde büyüme hormonu eksikliği tanı ve tedavi- si uzlaşı raporu (Bölüm 1): Büyüme hormon eksikliği tanısı. Çocuk Dergisi 2006; 6:11-6. short stature. A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 1995; 127:857-67. the use of recombinant human growth hormone in children. American Academy of Pediatrics Committee on Drugs and Committee on Bioethics. Pediatrics; 1997; 99:122-9. atment of growth hormone deficiency in children and adoles- cents; towards a consensus. Horm Res 1998; 50:320-40. GH Research Society. Consesus Guidelines for the diganosis and treatment of growth hormone (GH) deficiency in childho- od and adolescence: Summary statement of the GH research society. J Clin Endocrinol Metab 2000; 11:3990-3. Pediatric Endocrinology Society Drug and Therapeutics Committee. Update of guidelines for the use of growth hormo- ne in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003; 143:415-21. nosis of growth hormone deficiency in children and adults. Endocr Rev 1998; 19:203-23. Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm IGF Res 2001; 11:137-65. Keizer Schrama S. Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency. Horm Res 2002; 13. Ulusal Pediatrik Endokrinoloji Derneği adına Darendeliler F, Darcan Ş. Çocukluk ve ergenlik döneminde büyüme hor- monu eksikliği tanı ve tedavisi uzlaşı raporu (Bölüm 2) Büyüme hormonu eksikliği tedavisi. Çocuk Dergisi 2006; 6:89-94. human growth hormone administration: Statement from the growth hormone research society. J Clin Endocrinol Metab 2001; 86:1868-70. Sizonenko PC. Diagnosis and management of growth hormo- ne deficiency in childhood and adolescence -Part 2: Growth hormone treatment in growıh hormone deficient children. Growth Hormone & IGF Research 2002; 12:323-41. Growth